Skip to main content
    S

    SAB Biotherapeutics Inc (SABS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.95
    -0.05 (-1.67%)

    Market Cap: $266.66M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    SAB Biotherapeutics Inc (SABS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    SAB Biotherapeutics (SABS) has a latest price of $2.95 on Nov 17, 2026, 42.7% below its 52-week high of $5.15. Its price fell 9.0% over the past 12 months. The month-end price fell 95.8% over the 5 years through Oct 2026, a compound annual decline of 46.9%.

    Price Chart

    From Feb 2021 to Oct 2026, its highest month-end close was $108.90 in Nov 2021 and its lowest $1.36 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart SABS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SABS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 22.0%, and over 6 months it fell 16.9%. The month-end price fell 66.5% over the 3 years through Oct 2026, a compound annual decline of 30.5%.

    PeriodChange
    1 month+13.5%
    3 months-22.0%
    6 months-16.9%
    12 months-9.0%
    12 months, with dividends-9.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-66.5%-30.5%
    5 years-95.8%-46.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 16.5%, and its weakest was 2022, when it fell 92.4%.

    YearCloseChange
    2026 through Oct 2026$3.35-10.4%
    2025$3.74-1.4%
    2024$3.79-44.8%
    2023$6.88+16.5%
    2022$5.90-92.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 4.7% below its 50-day average of $3.09 and 18.4% below its 200-day average of $3.61.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.95
    52-week high$5.15-42.7%
    52-week low$2.44+20.9%
    50-day average$3.09-4.7%
    200-day average$3.61-18.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.6%.

    MeasureValue
    1-year beta1.07
    Largest fall, 1 year-45.8%
    Largest fall, 3 years-88.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About SABS

    What is SABS's 1-year price change?

    SAB Biotherapeutics's price fell 9.0% over the past 12 months. With dividends included, the 12-month total return was -9.0%.

    What is SABS's 5-year price change?

    SAB Biotherapeutics's month-end price fell 95.8% over the 5 years through Oct 2026, a compound annual decline of 46.9%. These figures leave out dividends.

    What is SABS's 52-week high and low?

    SAB Biotherapeutics's 52-week high is $5.15 and its 52-week low is $2.44. Its latest price of $2.95 on Nov 17, 2026 is 42.7% below the high.

    What is SABS's beta?

    SAB Biotherapeutics's 1-year beta against the S&P 500 is 1.07, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 45.8%.

    Is the SABS chart free?

    Yes. Advanced Charting for SABS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.